Antithrombin concentrates may benefit cardiopulmonary bypass patients with suspected heparin resistance: A retrospective analysis of real-world data

Antithrombin concentrates may benefit cardiopulmonary bypass patients with suspected heparin resistance: A retrospective analysis of real-world data

Background: Heparin resistance is a common complication of surgical patients requiring anticoagulation, such as those undergoing cardiopulmonary bypass (CPB). Treatments to address heparin resistance include supplementation of antithrombin (AT) or fresh frozen plasma (FFP). This retrospective databa...

Full description

Bibliographic Details
Main Authors: Stephen O. Bader, Xavier F. Marinaro, Glenda Stone, Kunal Lodaya, Jeffrey B. Spears, Aryeh Shander
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Heliyon
Subjects:
Antithrombin
Heparin resistance
Fresh frozen plasma
Cardiac surgery
Cardiopulmonary bypass
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023067051

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023067051

Similar Items